| Predictors of anti-TNF treatment failure in anti-TNF-naive patients with active luminal Crohn's disease: a prospective, multicentre, cohort study NA Kennedy, GA Heap, HD Green, B Hamilton, C Bewshea, GJ Walker, ... The lancet Gastroenterology & hepatology 4 (5), 341-353, 2019 | 588 | 2019 |
| Lactobacilli and bifidobacteria in the prevention of antibiotic-associated diarrhoea and Clostridium difficile diarrhoea in older inpatients (PLACIDE): a randomised, double … SJ Allen, K Wareham, D Wang, C Bradley, H Hutchings, W Harris, A Dhar, ... The Lancet 382 (9900), 1249-1257, 2013 | 525 | 2013 |
| HLA-DQA1* 05 carriage associated with development of anti-drug antibodies to infliximab and adalimumab in patients with Crohn’s disease A Sazonovs, NA Kennedy, L Moutsianas, GA Heap, DL Rice, M Reppell, ... Gastroenterology 158 (1), 189-199, 2020 | 315 | 2020 |
| Evaluation of a minimally invasive cell sampling device coupled with assessment of trefoil factor 3 expression for diagnosing Barrett's esophagus: a multi-center case–control study CS Ross-Innes, I Debiram-Beecham, M O'Donovan, E Walker, ... PLoS medicine 12 (1), e1001780, 2015 | 275 | 2015 |
| Narrow band imaging optical diagnosis of small colorectal polyps in routine clinical practice: the Detect Inspect Characterise Resect and Discard 2 (DISCARD 2) study CJ Rees, PT Rajasekhar, A Wilson, H Close, MD Rutter, BP Saunders, ... Gut 66 (5), 887-895, 2017 | 212 | 2017 |
| Common variants at the MHC locus and at chromosome 16q24. 1 predispose to Barrett's esophagus Esophageal Adenocarcinoma Genetics Consortium, ... Nature genetics 44 (10), 1131-1136, 2012 | 209 | 2012 |
| Cytosponge-trefoil factor 3 versus usual care to identify Barrett's oesophagus in a primary care setting: a multicentre, pragmatic, randomised controlled trial RC Fitzgerald, M di Pietro, M O'Donovan, R Maroni, B Muldrew, ... The Lancet 396 (10247), 333-344, 2020 | 199 | 2020 |
| Elastic scattering spectroscopy for the diagnosis of colonic lesions: initial results of a novel optical biopsy technique A Dhar, KS Johnson, MR Novelli, SG Bown, IJ Bigio, LB Lovat, SL Bloom Gastrointestinal endoscopy 63 (2), 257-261, 2006 | 142 | 2006 |
| Budesonide orodispersible tablets maintain remission in a randomized, placebo-controlled trial of patients with eosinophilic esophagitis A Straumann, AJ Lucendo, S Miehlke, M Vieth, C Schlag, L Biedermann, ... Gastroenterology 159 (5), 1672-1685. e5, 2020 | 141 | 2020 |
| SARS-CoV-2 vaccination for patients with inflammatory bowel disease: a British Society of Gastroenterology Inflammatory Bowel Disease section and IBD Clinical Research Group … JL Alexander, GW Moran, DR Gaya, T Raine, A Hart, NA Kennedy, ... The Lancet Gastroenterology & Hepatology 6 (3), 218-224, 2021 | 124 | 2021 |
| Risk stratification of Barrett's oesophagus using a non-endoscopic sampling method coupled with a biomarker panel: a cohort study CS Ross-Innes, H Chettouh, A Achilleos, N Galeano-Dalmau, ... The lancet Gastroenterology & hepatology 2 (1), 23-31, 2017 | 119 | 2017 |
| Polymorphisms near TBX5 and GDF7 are associated with increased risk for Barrett’s esophagus C Palles, L Chegwidden, X Li, JM Findlay, G Farnham, FC Giner, ... Gastroenterology 148 (2), 367-378, 2015 | 119 | 2015 |
| Mercaptopurine versus placebo to prevent recurrence of Crohn's disease after surgical resection (TOPPIC): a multicentre, double-blind, randomised controlled trial C Mowat, I Arnott, A Cahill, M Smith, T Ahmad, S Subramanian, S Travis, ... The lancet Gastroenterology & hepatology 1 (4), 273-282, 2016 | 110 | 2016 |
| and British Society of Paediatric Gastroenterology, Hepatology and Nutrition (BSPGHAN) joint consensus guidelines on the diagnosis and management of eosinophilic oesophagitis … A Dhar, HN Haboubi, SE Attwood, MKH Auth, JM Dunn, R Sweis, D Morris, ... Gut 71 (8), 1459-87, 2022 | 105 | 2022 |
| MHC class I chain-like gene A (MICA) and its associations with inflammatory bowel disease and peripheral arthropathy TR Orchard, A Dhar, JD Simmons, R Vaughan, KI Welsh, DP Jewell Clinical & Experimental Immunology 126 (3), 437-440, 2001 | 99 | 2001 |
| Optical properties of RF sputtered strontium substituted barium titanate thin films B Panda, A Dhar, GD Nigam, D Bhattacharya, SK Ray Thin Solid Films 332 (1-2), 46-49, 1998 | 97 | 1998 |
| A high-dose preparation of lactobacilli and bifidobacteria in the prevention of antibiotic-associated and Clostridium difficile diarrhoea in older people admitted to hospital … SJ Allen, K Wareham, D Wang, C Bradley, B Sewell, H Hutchings, ... Health Technology Assessment (Winchester, England) 17 (57), 1-140, 2013 | 90 | 2013 |
| British Society of Gastroenterology (BSG) and British Society of Paediatric Gastroenterology, Hepatology and Nutrition (BSPGHAN) joint consensus guidelines on the diagnosis and … A Dhar, HN Haboubi, SE Attwood, MKH Auth, JM Dunn, R Sweis, D Morris, ... Gut 71 (8), 1459-1487, 2022 | 74 | 2022 |
| Sucralfate enema in ulcerative rectosigmoid lesions R Kochhar, SK Mehta, R Aggarwal, A Dhar, F Patel Diseases of the colon & rectum 33, 49-51, 1990 | 71 | 1990 |
| Green endoscopy: British Society of Gastroenterology (BSG), Joint Accreditation Group (JAG) and Centre for Sustainable Health (CSH) joint consensus on practical measures for … S Sebastian, A Dhar, R Baddeley, L Donnelly, R Haddock, ... Gut 72 (1), 12-26, 2023 | 66 | 2023 |
Mike GravenorProfessor of Biostatistics and Epidemiology, Swansea University在 swan.ac.uk 的电子邮件经过验证
